Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

India Cuts API Imports, Disburses Rs 1,008 Cr Under PLI Schemes, Parliament Told

High-Alcohol Medicinal Preparations to Come Under Schedule H1: Govt Panel Approves Rule Change

Farhat Nasim4 July 2025 12:00 PM IST

New Delhi: The Drugs Consultative Committee (DCC) has agreed to amend the Drugs Rules, 1945 to regulate the alcohol content in tinctures and other...

Delhi HC directs private hospital to treat minor boy under EWS category after govt hospitals denied admission over ICU bed shortage

Delhi HC Flags Off-Label Use of Diabetes Drugs for Weight Loss, Seeks CDSCO Report

Farhat Nasim3 July 2025 9:27 PM IST

New Delhi: The Delhi High Court has directed the Central Drugs Standard Control Organisation (CDSCO) and the Drug Controller General of India (DCGI)...

Manipal Outbids Blackstone, Fortis to Lead Race for Sahyadri Hospitals with Rs 6,838 Cr Offer

Farhat Nasim2 July 2025 4:46 PM IST

New Delhi: Manipal Health Enterprises (MHE), India's second-largest hospital chain, has emerged as the frontrunner to acquire Sahyadri Hospitals, with...

Piramal Gets Delhi HC Relief, Decades-Old Spurious Tixylix Cough Syrup Case Quashed

Delhi HC Rejects Modi-Mundipharma's Monopoly Claim Over 'CONTIN', Allows Limited Relief

Farhat Nasim2 July 2025 4:45 PM IST

New Delhi: Noting that a pharma company cannot claim monopoly over descriptive elements like "FE" and "CONTIN" used generically in the industry, the...

Puducherry’s Medical Students Join the Fight Against TB

DCC Recommends Licensing, Labelling Restrictions on Anti-TB Drugs to Curb Private Market Misuse

Farhat Nasim1 July 2025 11:07 PM IST

New Delhi: In a move to curb potential misuse of critical tuberculosis medications, the Drugs Consultative Committee (DCC) has recommended that...

JB Chemicals Panoli facility concludes USFDA inspection no observations

After Much Tussle, Torrent Pharma Clinches JB Chemicals Deal at Rupees 25,689 Crore Valuation

Farhat Nasim30 Jun 2025 3:07 PM IST

Mumbai: The JB Pharma divestment saga has finally seen its fate as Torrent Pharmaceuticals Limited and global investment firm KKR announced that...

Pharma Firms To Face Periodic Inspection As HC Flags Effluent Risks

Farhat Nasim29 Jun 2025 8:00 PM IST

Sikkim: The High Court of Sikkim has disposed of a Public Interest Litigation (PIL) concerning the unauthorised release of effluents and extraction of...

Health Ministry Plans Licence Suspension for Drugs Failing Quality Standards: Report

Farhat Nasim26 Jun 2025 8:01 PM IST

New Delhi: The Union Health Ministry is planning a regulatory overhaul that could result in the immediate suspension of product licenses for...

One Death a Day: 1,705 Lives Lost in Indias Clinical Trials Since 2021, RTI Reveals

58 Unauthorised Clinical Trials Spark DCGI Ban on VS Hospital, Doctors, Pharma Giants Under Fire

Farhat Nasim25 Jun 2025 5:35 PM IST

Ahmedabad: The Drugs Controller General of India (DCGI) has barred VS Hospital from conducting any further clinical trials after an official probe...

Andhra Pradesh allotts 531.77 acres of land to Laurus Labs

Laurus Labs Asked to Submit Justification, Data for Pediatric Darunavir-Ritonavir FDC Proposal

Farhat Nasim23 Jun 2025 3:30 PM IST

New Delhi: The Subject Expert Committee (SEC) on Antimicrobial & Antiviral under the Central Drugs Standard Control Organisation (CDSCO) has asked...

State Drug Alert: Ciprofloxacin, Lorazepam, Albendazole Among 97 NSQ Samples Flagged in July

State Drug Alert: CDSCO Flags 128 Batches Including Paracetamol, Dapagliflozin

Farhat Nasim22 Jun 2025 3:00 PM IST

New Delhi: As part of its ongoing quality surveillance efforts, the Central Drugs Standard Control Organisation (CDSCO) has flagged more than 120...

46 Drug Batches Fail CDSCO Quality Test In July, Details

58 Drug Batches, Including Dexona Fail CDSCO Quality Standards

Farhat Nasim21 Jun 2025 8:08 PM IST

New Delhi: In its continued effort to ensure drug safety and compliance, the Central Drugs Standard Control Organisation (CDSCO) has flagged 58...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok